Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced the availability of TECNIS Synergy™ Toric II OptiBlue® PC-IOL for patients with astigmatism inside India. TECNIS Synergy™ Toric II IOL, is a continuous-range-of-vision lens engineered for rotational stability, which locks in visual performance and provides high-quality vision1.
Cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, with a lot more than 90% of people developing cataracts by the age of 65. 2, 3 Most individuals will develop cataracts at some point in their life, and modern cataract surgery is really a safe plus effective treatment that has a success rate of nearly 98%. 4 In India , nearly 73% of adults 60 years and older have cataracts5 plus if left untreated, cause vision to deteriorate over time. Astigmatism reduces distance and near visual acuity, vision quality, plus depth perception. 6, 7 All cataracts will eventually need in order to be surgically removed and replaced with an artificial lens, called an IOL (Intraocular lens).
Burzin Shahana, Country Manager at Johnson & Johnson Vision, Surgical Eyesight India , said, ”At Johnson & Johnson Vision, we are deeply engaged with Indian health care professionals to reduce cataract burden through innovative, quality-based technologies plus products. TECNIS Synergy™ Toric II OptiBlue® PC-IOL is an advanced IOL solution for cataract patients along with astigmatism and gives patients the visual clarity and increased spectacle independence to improve their current lifestyles. ” He also added, ”The launch will also expand available options physicians have to provide value to their patients with astigmatism. ” New TECNIS Synergy™ Toric II OptiBlue® PC-IOL (Intraocular Lens) offers an opportunity to address both presbyopia and astigmatism in the time of cataract surgery. 8 It’s designed to: • Provide high-quality, continuous vision over a full range of distances, including far, intermediate plus near, in order to increase spectacle independence. These Toric IOLs compensate with regard to corneal spherical aberration and corneal astigmatism. 1 • The posterior optic associated with the zoom lens has a proprietary diffractive surface designed to correct chromatic aberration for enhanced contrast sensitivity and offer high-quality eyesight over a full range of distances. The diffractive design of this lens leads to high visible acuities across all ranges and a continuous range of vision from far through near, resulting in improved spectacle self-reliance. 1 • New frosted haptic design increases the amount of friction between the particular lens haptic surface plus the capsular bag in order to lock in the Intraocular Lens regarding rotational stability and visual performance.
Within India , TECNIS Synergy™ Toric II OptiBlue® PC-IOL has been approved by the Central Drugs Standard Control Organisation (CDSCO).
About Johnson & Manley Vision* At Johnson & Johnson Eyesight, part associated with Johnson & Johnson Healthcare Devices Companies, we have the bold ambition: to change the particular trajectory of eye wellness worldwide. Through our operating companies, we deliver innovation that enables eye care experts to create better outcomes intended for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts, and dry eye. In communities along with greatest need, we work in collaboration to expand access to quality vision care, and we are committed to helping people see better, connect better, live better.
About Johnson & Johnson Medical Devices Companies** At Johnson & Manley Medical Devices Companies, we are assisting people reside their best lives. Building on more than a century associated with expertise, all of us tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, eyesight, and interventional solutions, we are helping in order to save lives and paving the way to the healthier future for everyone, everywhere.
*Johnson & Johnson Vision represents the products and services associated with Johnson & Johnson Surgical Vision, Inc. , Johnson & Manley Vision Care, Inc. , and the particular affiliates of both. **The Johnson & Johnson Medical Devices Businesses comprise the surgery, orthopedics, vision, plus interventional solutions businesses within Johnson & Johnson’s Healthcare Devices segment.
1 TECNIS Synergy™ Toric II OptiBlue® IOL Pack Insert 2 World Health Organization. Blindness and Impairment. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment a few Kellogg Eye Center. Cataract. www.umkelloggeye.org/conditions-treatments/cataract 4 Vision Wellness Initiative, Common Eye Disorders. Centers to get Disease Control and Prevention. https://www.cdc.gov/visionhealth/basics/ced/index.html 5 Vashist P, Talwar B, Gogoi M, Maraini G, Camparini M, Ravindran RD, Murthy GV, Fitzpatrick KE, John N, Chakravarthy U, Ravilla TD, Fletcher AE. Prevalence associated with cataract inside an older population within India: the particular India study of age-related eye disease. Ophthalmology. 2011 Feb; 118(2): 272-8. e1-2. 6 Wolffsohn JS, Bhogal G, Shah S (2011) Effect of uncorrected astigmatism on vision. J Cataract Refract Surg 37 (3): 454-460. seven Read SA, Vincent SJ, Collins MJ (2014) The particular visual and functional impacts of astigmatism and its clinical management. Ophthalmic Physiol Opt 34 (3): 267-294.
7 8 https://www.beyondcataracts.com/cataract-treatment/tecnis-synergy-iols – accessed on 4th Nov’22 PP2022CT5406
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed. )